Projects per year
Personal profile
Personal profile
Dr. Bing Liao is Board Certified for Neurology, Neuromuscular Medicine and Electrodiagnostic Medicine. She is specialized in wide range of neuromuscular disorders: neuropathy, amyotrophyic lateral sclerosis (ALS), myasthenia gravis, inflammatory myopathy and muscular dystrophy. She is also specialized in various headache syndromes. She performs electrodiagnostic testing, botulinum toxin injections and occipital nerve blocks.
Research interests
Dr. Liao's research interests include laboratory and clinical studies of new therapies for myasthenia gravis, congenital myasthenic syndrome, muscular dystrophy, ALS, CIDP and cancer related neuromuscular disorders. Dr. Liao has been the recipient of several awards and honors through the course of her professional career, including “The American Police Hall of Fame, Life Saving Award”.
Dr. Liao has authored and co-authored many published manuscripts in peer-reviewed clinical and scientific journals, and presented at numerous national and international scientific and clinical annual meetings and conferences.
Research Area Keywords
- Neurosciences
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Home Visits are the Answer for Homebound Patients with Amyotrophic Lateral Sclerosis
5/9/24 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix A - For 0.3mh/kg SC zilucoplan administered once daily and placebo
Appel, S. H., Shroff, S., Greene, E. P. & Liao, B.
7/24/20 → 7/23/25
Project: Non Profit
-
Compound Muscle Action Potential and Myosin-Loss Pathology in Patients with Critical Illness Myopathy: Correlation and Prognostication
Shelly, S., Soontrapa, P., Madigan, N. N., Polzin, M. J., Singh, T. D., Sista, S. R. S., Paul, P., Braksick, S. A., Liao, B., Windebank, A. J., Boon, A. J., Litchy, W. J., Milone, M. & Liewluck, T., Jun 13 2024, In: Neurology. 103, 1, e209496.Research output: Contribution to journal › Article › peer-review
-
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development
for the Healey ALS Platform Trial Study Group, HEALEY ALS Platform Trial Study Group, Biostatisticians, Investigators, Clinical Operations Team & Medical Monitors, Feb 1 2022, In: Annals of Neurology. 91, 2, p. 165-175 11 p.Research output: Contribution to journal › Article › peer-review
Open Access47 Scopus citations -
Brachial Plexopathies: Update on Treatment
Shanina, E., Liao, B. & Smith, R. G., May 1 2019, In: Current Treatment Options in Neurology. 21, 5, 24.Research output: Contribution to journal › Review article › peer-review
9 Scopus citations -
Neurological complications associated with anti–programmed death 1 (PD-1) antibodies
Kao, J. C., Liao, B., Markovic, S. N., Klein, C. J., Naddaf, E., Staff, N. P., Liewluck, T., Hammack, J. E., Sandroni, P., Finnes, H. & Mauermann, M. L., Oct 2017, In: JAMA Neurology. 74, 10, p. 1216-1222 7 p.Research output: Contribution to journal › Article › peer-review
245 Scopus citations -
Alternating ptosis associated with asialo-GM1 and GD1b antibodies
Liao, B., Kamiya-Matsuoka, C., Fang, X., Smith, R. G. & Shanina, E., Dec 1 2016, In: International Journal of Neuroscience. 126, 12, p. 1139-1141 3 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations